المؤلفون: K. L. Buechel, Kenneth C. Lasseter, S.-L. Yao, Hui Quan, C. F. Ryan, C. P. Gumbs, O. Obrda, Thomas Musliner, Jules I. Schwartz, Patrick J. Larson, Manuel B. Pinto, Stacy C. Dilzer, Barry J. Gertz, D. C. Brater, David W. Rudy, David L. Ebel, Suzanne K. Swan, L. J. Lambrecht, Kimberly J. Sundblad

المصدر: Annals of internal medicine. 133(1)

مصطلحات موضوعية: Male, medicine.medical_specialty, Urinary system, Indomethacin, Renal function, Placebo, Kidney, Gastroenterology, Lactones, Indometacin, Double-Blind Method, Internal medicine, Internal Medicine, medicine, Humans, Cyclooxygenase Inhibitors, Single-Blind Method, Sulfones, Adverse effect, Rofecoxib, Aged, Aged, 80 and over, Cross-Over Studies, Cyclooxygenase 2 Inhibitors, business.industry, Anti-Inflammatory Agents, Non-Steroidal, Sodium, Membrane Proteins, General Medicine, Diet, Sodium-Restricted, medicine.disease, Crossover study, Isoenzymes, Endocrinology, Cyclooxygenase 2, Prostaglandin-Endoperoxide Synthases, Creatinine, Potassium, Female, business, medicine.drug, Kidney disease, Glomerular Filtration Rate

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c26daccf238841e2c6e24978158b51
https://pubmed.ncbi.nlm.nih.gov/11388825